Doping-Control Analysis of the 5α-Reductase Inhibitor Finasteride: Determination of Its Influence on Urinary Steroid Profiles and Detection of Its Major Urinary Metabolite

    April 2007 in “ Therapeutic Drug Monitoring ”
    Mario Thevis, Hans Geyer, Ute Mareck … Wilhelm Schänzer
    Studysummary This study found that finasteride significantly alters urinary steroid profiles, complicating the detection of steroid abuse in doping-control analysis by potentially causing false-negative results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on journals.lww.com →
    Discuss this study in the Community →

    Research cited in this study 9

    1. Medicolegal Aspects of Doping in Football British Journal of Sports Medicine · 2006
    2. Changes in Hair Weight in Men with Androgenetic Alopecia After Treatment with Finasteride (1 mg Daily): Three- and Four-Year Results Journal of The American Academy of Dermatology · 2006
    3. Inhibitors of 5α-Reductase in the Treatment of Benign Prostatic Hyperplasia Current pharmaceutical design · 2006
    4. Steroidogenic Isoenzymes in Human Hair and Their Potential Role in Androgenetic Alopecia Dermatology · 2003
    5. Male Androgenetic Alopecia Clinical and Experimental Dermatology · 2002
    6. Separation of Finasteride and Analogues Journal of Chromatography B: Biomedical Sciences and Applications · 2001
    7. Clinical Application of 5α-Reductase Inhibitors Journal of endocrinological investigation · 2001
    8. Finasteride Drugs · 1999
    9. Finasteride, a Type 2 5α-Reductase Inhibitor, in the Treatment of Men with Androgenetic Alopecia Expert Opinion on Investigational Drugs · 1999

    Related research 1

    1. Effect of Finasteride, a 5 Alpha-Reductase Inhibitor, on Serum Gonadotropins in Normal Men The Journal of Clinical Endocrinology and Metabolism · 1992